Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging has reported quarterly revenue of $3.4 million, marking an increase from $3.0 million in the prior quarter, attributed to stronger teleradiology utilization and improved margins. The company has reaffirmed its goal to surpass 100 deployed units globally by year-end and has issued a robust revenue guidance of $35 million for 2026, indicating confidence in unit placement and monetization across various revenue channels. Additionally, a strategic partnership with 3DR Labs to distribute its AI imaging solutions across over 1,800 hospitals enhances its commercial footprint and supports future growth prospects for its imaging ecosystem.

Bears say

Nano X Imaging Ltd's cash reserves have decreased significantly from $83.2 million to $55.5 million, primarily due to an operating cash burn of $30.4 million, indicating financial strain. The company has also been adjusting its revenue growth expectations downward over the past year, signaling potential challenges in market demand or operational effectiveness. Furthermore, the sustained GAAP gross loss of $2.9 million and consistent net loss of $13.7 million highlight ongoing financial difficulties tied to investments in system deployments and AI infrastructure.

Nano-X Imaging (NNOX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 2 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.